University Of Chicago
Clinical trials sponsored by University Of Chicago, explained in plain language.
-
Heart pump patients get new hope from diabetes drug
Disease control CompletedThis study looked at whether a type of diabetes medicine called SGLT2 inhibitors can help people with severe heart failure who also have a mechanical heart pump (LVAD). Researchers measured changes in heart size, weight, and kidney function over 6 months in 32 adults. The goal wa…
Phase: PHASE4 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Immunotherapy drug may delay return of aggressive head and neck cancers
Disease control CompletedThis study tested whether giving the immunotherapy drug pembrolizumab for one year after standard treatment could help prevent head and neck cancer from coming back in 100 patients at high risk for recurrence. Participants received either pembrolizumab or a placebo. The main goal…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immune booster shows promise against rare cancer
Disease control CompletedThis study tested a drug called pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the immune system attack cancer cells. The goal was to see if it could shrink tumors or slow the disease, but…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail aims to deepen remissions in myeloma patients
Disease control CompletedThis phase 2 trial tested a combination of three drugs—carfilzomib, lenalidomide, and dexamethasone—given before and after a stem cell transplant in 76 people newly diagnosed with multiple myeloma. The goal was to see how many patients achieved a very deep remission (stringent co…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy for tough prostate cancer shows promise in early trial
Disease control CompletedThis early-phase study tested a new combination of two drugs—enzalutamide and relacorilant—in 42 men with advanced prostate cancer that no longer responds to standard hormone therapy. The main goals were to check safety and see how the drugs interact in the body. Researchers also…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Diabetes drug metformin may boost chemo for ovarian cancer
Disease control CompletedThis phase II trial tested whether adding metformin, a common diabetes drug, to standard chemotherapy could help control advanced ovarian, fallopian tube, or primary peritoneal cancer. 111 participants received either metformin or a placebo alongside chemotherapy, followed by mai…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo shows promise for tough lymphomas
Disease control CompletedThis study tested adding lenalidomide to a standard chemotherapy regimen (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the best dose and see if the combination improves how long patients live without their cancer getting wors…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Fiber fix for peanut allergy? small study tests prebiotic boost to OIT
Disease control CompletedThis small pilot study tested whether adding a prebiotic fiber (a type of plant fiber found in grocery stores) to peanut oral immunotherapy could help children aged 4 to 17 with peanut allergy tolerate more peanut protein with fewer side effects. Twenty children participated, and…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a smartphone app tame high blood pressure in african americans?
Disease control CompletedThis study tested a mobile app called USeeBP in 31 African American adults with poorly controlled high blood pressure. Participants used the app alongside their usual remote monitoring program to track blood pressure readings at home. The goal was to see if the app could help imp…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Heart drug metoprolol may shield patients from Post-Surgery heart injury
Disease control CompletedThis study tested whether metoprolol, an FDA-approved heart medication, can reduce heart damage after surgery in people with coronary artery disease. 72 adults aged 50 and older who were not already on beta-blockers took part. The drug was given after anesthesia and during hospit…
Phase: PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy shows promise for myeloma patients with remaining disease
Disease control CompletedThis study looked at 42 people with multiple myeloma that was still present after a stem cell transplant. It compared continuing lenalidomide alone versus adding two other drugs (ixazomib and dexamethasone) to try to eliminate the remaining cancer. The goal was to see which appro…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Powerful cocktail shows promise against bone marrow cancer
Disease control CompletedThis phase 2 trial tested a combination of four drugs—elotuzumab, carfilzomib, lenalidomide, and dexamethasone—in 46 people newly diagnosed with multiple myeloma. The goal was to see how many patients achieved a very deep response (stringent complete response or minimal residual …
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug cocktail shows promise for Tough-to-Treat myeloma
Disease control CompletedThis study tested a combination of three drugs (pomalidomide, dexamethasone, and carfilzomib) in 25 people with multiple myeloma that had come back or stopped responding to prior treatments. The goal was to find the safest dose and see how well the drugs worked together to contro…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a phone call and a community referral help older adults control diabetes?
Disease control CompletedThis completed trial tested two programs for older adults with type 2 diabetes: one with monthly phone coaching and one that added personalized referrals to community resources. Over 500 participants were followed for a year to see if these approaches helped lower blood sugar lev…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Drug duo may unlock kidney transplants for 'impossible' patients
Disease control CompletedThis pilot study tested a combination of two drugs—belatacept and a proteasome inhibitor—to lower strong immune antibodies in 5 highly sensitized kidney transplant candidates. The goal was to increase their chances of finding a compatible donor. The study has completed, but resul…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can removing certain immune cells make stem cell transplants safer for myeloma patients?
Disease control CompletedThis early study tested whether removing a specific type of immune cell (regulatory T cells) is safe in 30 people with multiple myeloma undergoing a stem cell transplant. Participants received standard transplant drugs plus a procedure to deplete these cells. The goal was to see …
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control CompletedThis early-phase trial tested a combination of three drugs—selinexor, carfilzomib, and dexamethasone—in 52 patients with multiple myeloma that had returned or stopped responding to treatment. The main goal was to find the safest dose and check for side effects. Researchers hope t…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New care plan after heart pump surgery shows promise
Disease control CompletedThis study tested a standardized care plan to protect the right side of the heart after a left ventricular assist device (LVAD) implant. Twenty adults receiving an LVAD were given either the standardized care or usual care. The goal was to see if the new approach could prevent ri…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Sleep more, slash diabetes risk? small study tests the idea.
Disease control CompletedThis study looked at whether getting more sleep or keeping a regular bedtime could improve how the body handles sugar and insulin in overweight adults who usually sleep less than 7 hours a night. Eighteen African American men and women aged 21-50 were asked to either extend their…
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 26, 2026 16:59 UTC
-
New strategies boost HIV prevention pills for black women in the south
Prevention CompletedThis study tested four practical strategies—training providers, educating patients, improving electronic health records, and offering patient navigation—to increase use of HIV prevention pills (PrEP) among Black women. Over 700 women from 12 community clinics in the Midwest and S…
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Vitamin d doses tested as COVID-19 shield in chicago study
Prevention CompletedThis study looked at whether taking different amounts of vitamin D could lower the risk of getting COVID-19. About 1,475 adults from the Chicago area took either a low (400 IU), moderate (4,000 IU), or high (10,000 IU) daily dose of vitamin D for 9 months. Researchers tracked who…
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Vitamin d duel: does a higher dose ward off COVID?
Prevention CompletedThis study looked at whether taking a moderate dose (4,000 IU) of vitamin D daily could lower the chance of getting COVID-19 compared to a low dose (400 IU). Over 2,000 adults in the US took part for 12 months. The goal was to see if vitamin D can help prevent COVID-19 infection.
Phase: NA • Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Could a new pill ease borderline personality disorder symptoms?
Symptom relief CompletedThis study tested whether Caplyta (lumateperone), a drug already used for other mental health conditions, can reduce symptoms of borderline personality disorder (BPD). Sixty adults with BPD received either Caplyta or a placebo pill for 8 weeks. Researchers measured changes in BPD…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Body fat to the rescue: new study tests fat grafts for radiation burns
Symptom relief CompletedThis study looked at whether taking fat from one part of the body and moving it to a breast that was damaged by radiation can help the tissue heal. Ten women who had radiation for breast cancer took part. The goal was to see if this fat transfer could make the skin softer and les…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Better sleep, better stroke recovery? new study tests simple hospital changes
Symptom relief CompletedThis study tested a program called SIESTA-Rehab to help stroke patients sleep better during their hospital stay. The program included training nurses to reduce nighttime disruptions and a plan to check for and treat sleep apnea. Researchers studied 400 adults in a rehab hospital …
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
CBD drug shows promise for OCD and tics in tiny study
Symptom relief CompletedThis small study tested whether Epidiolex (a prescription CBD oil) can safely reduce symptoms of obsessive-compulsive disorder, hair-pulling, Tourette syndrome, and hoarding. Four adults took the drug for two weeks. The goal was to see if symptoms improved and if the drug was wel…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Less pressure, less pain? new study tests simple change during robotic surgery
Symptom relief CompletedThis study looked at 70 women having robotic surgery for pelvic organ prolapse. It compared standard gas pressure (15 mmHg) to a slightly lower pressure (12 mmHg) during the operation. The main goal was to see if the lower pressure led to less pain right after surgery, without ma…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New ER tool aims to better detect pain in dementia patients
Symptom relief CompletedThis study tested whether a special pain scale called PAINAD, built into the electronic health record, helps emergency room staff better assess and treat pain in older adults with dementia who come in with hip pain. The study included 714 patients and measured how often the scale…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Magic mushroom compound shows promise for Tough-to-Treat depression and BPD
Symptom relief CompletedThis small Phase 2 trial tested a single 25mg dose of psilocybin in 9 adults with both major depressive disorder and borderline personality disorder. Researchers measured changes in depression and BPD symptoms over time. The goal was to see if psilocybin is safe and could help ea…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can AI and VR ease anxiety in IBD patients? small study explores digital wellness
Symptom relief CompletedThis small study tested whether an AI-powered virtual reality app could safely provide mental health support to 22 adults with inflammatory bowel disease (IBD) who also had mild anxiety or depression. The goal was to see if the digital session was practical and acceptable, not to…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Cool your head, sleep better? new study tests a pillow pad for Weight-Related sleep problems
Symptom relief CompletedThis study tested whether a special cooling pillow pad called Moona can help African American adults with overweight or obesity sleep better. 18 participants used either the active cooling pad or an inactive version for 22 days. Researchers measured sleep quality, timing, and blo…
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Heart ablation after pouch closure: new registry data collected
Knowledge-focused CompletedThis study gathered information from routine medical care for 198 adults with atrial fibrillation who had a prior procedure to close a small heart pouch (left atrial appendage occlusion) and later needed a heart ablation. Researchers looked at patient details, procedure steps, bl…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Video training may cut infection risk for home nutrition patients
Knowledge-focused CompletedThis study tested whether an educational video on safe catheter care could reduce bloodstream infections in adults starting home parenteral nutrition for the first time. Twenty-five participants received the video training alongside standard care. Researchers tracked infection ra…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Could a simple surgery replace lifelong hormone shots for prostate cancer?
Knowledge-focused CompletedThis study looked at whether an educational session about orchiectomy (surgery to remove the testicles) would make more men with prostate cancer choose it over lifelong hormone therapy. 101 men who were already on hormone therapy for at least a year took part. The goal was to see…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Global registry aims to improve heart pacing for rhythm disorders
Knowledge-focused CompletedThis study gathered information from 383 people with slow heartbeats or heart failure who received a special type of pacemaker called conduction system pacing. Researchers looked at how well the device worked, any complications, and changes in heart function over 12 months. The g…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Fat cell clocks ticked before and after weight loss surgery
Knowledge-focused CompletedThis study looked at how daily rhythms—like sleep and meal timing—affect fat cell genes and insulin response in 28 women with obesity scheduled for bariatric surgery. Researchers used timed lights and meals to align or disrupt the body's internal clock, then measured changes in f…
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can a phone call help cancer survivors get the genetic answers they need?
Knowledge-focused CompletedThis study looked at whether offering genetic counseling by phone or video could help more childhood cancer survivors get genetic testing. About 391 survivors took part, comparing remote counseling to usual care. The goal was to see if remote services increase testing uptake and …
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Ultrasound peek inside ICU Patients' breathing muscles
Knowledge-focused CompletedThis study looked at 66 ICU patients on breathing machines to see if ultrasound could measure diaphragm thickness differently depending on the machine's settings. Researchers compared two modes: one where the machine controls all breaths and one where the patient triggers some br…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC